We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

9 hedge funds and large institutions have $836K invested in Biostar Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

29% more funds holding

Funds holding: 7 → 9 (+2)

7% more capital invested

Capital invested by funds: $780K → $836K (+$56K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$33.8K
2
ISB
Iowa State Bank
Iowa
+$14.2K
3
VKH
Virtu KCG Holdings
New York
+$12.8K
4
TRCT
Tower Research Capital (TRC)
New York
+$233

Top Sellers

Rank Fund Capital Flow
1
SIM
Spark Investment Management
New York
-$22K
2
Morgan Stanley
Morgan Stanley
New York
-$11.5K
3
Citadel Advisors
Citadel Advisors
Florida
-$5.36K
4
UBS Group
UBS Group
Switzerland
-$1.08K

BSPM Hedge Fund Activity: Q1 2015 in Review

9 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q1 2015, worth a combined $836K — up 7.2% from $780K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BSPM positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $33.8K. The largest seller was Spark Investment Management, exiting entirely with an estimated $22K sold.

  • 9 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q1 2015, up from 7 in Q4 2014.
  • Funds reported $836K of Biostar Pharmaceuticals, Inc. stock for Q1 2015, up 7.2% quarter-over-quarter.
  • 3 funds opened new Biostar Pharmaceuticals, Inc. positions in Q1 2015 and 1 closed out, a net change of +2 holders.
  • The largest Biostar Pharmaceuticals, Inc. buyer in Q1 2015 was Renaissance Technologies, an estimated $33.8K added.
  • The largest Biostar Pharmaceuticals, Inc. seller in Q1 2015 was Spark Investment Management, an estimated $22K sold.

Based on aggregated 13F filings for Q1 2015.